General Biologicals Corp. (4117) Stock Price & Analysis
4117 Stock Chart & Stats
- Day’s Range
- TWD 6.84 - TWD 9.57
- 52-Week Range
- TWD 3.50 - TWD 17.30
- Previous Close
- TWD 8.03
- Volume
- N/A
- Average Volume (3M)
- 191.19K
- Market Cap
- TWD 616.17M
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 606.76M
- Total Debt (Recent Filing)
- TWD 2.53B
- Price to Earnings (P/E)
- 1.0
- Beta
- -0.37
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
4117 FAQ
What was General Biologicals Corp.’s price range in the past 12 months?
What is General Biologicals Corp.’s market cap?
When is General Biologicals Corp.’s upcoming earnings report date?
Is General Biologicals Corp. overvalued?
Does General Biologicals Corp. pay dividends?
What is General Biologicals Corp.’s EPS estimate?
How many shares outstanding does General Biologicals Corp. have?
Which hedge fund is a major shareholder of General Biologicals Corp.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
General Biologicals Corp.
General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
- Sector
- General
- Industry
- Medical - Specialties
- CEO
- Frank Lin
- Employees
- 200
- Website
- www.gbc.com.tw
- Address
- No. 6, Innovation First Road, Hsinchu City, 300092, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 6 | 5 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 10 | 0 | 2 |

